Cargando…

Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation

BACKGROUND: Few studies have evaluated the quality of oral anticoagulant management by community pharmacists. There is no complete set of quality indicators available for this purpose. OBJECTIVE: To develop a set of specific quality indicators to assess oral anticoagulant management by community pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chartrand, Mylène, Guénette, Line, Brouillette, Denis, Côté, Stéphane, Huot, Roger, Landry, Jérôme, Martineau, Josée, Perreault, Sylvie, White-Guay, Brian, Williamson, David, Martin, Élisabeth, Gagnon, Marie-Mireille, Lalonde, Lyne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397915/ https://www.ncbi.nlm.nih.gov/pubmed/29578847 http://dx.doi.org/10.18553/jmcp.2018.24.4.357

Ejemplares similares

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)

Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge
por: Qazi, Jakub Z., et al.
Publicado: (2021)

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Concordance of care processes between medical records and patient self-administered questionnaires
por: Khanji, Cynthia, et al.
Publicado: (2019)

Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada
por: Laliberté, Marie-Claude, et al.
Publicado: (2012)

Identifying heavy health care users among primary care patients with chronic non-cancer pain
por: Antaky, Elie, et al.
Publicado: (2017)

Pharmacists practising in family medicine groups: An evaluation 2 years after experiencing a virtual community of practice
por: Guénette, Line, et al.
Publicado: (2021)

Costs of moderate to severe chronic pain in primary care patients – a study of the ACCORD Program
por: Lalonde, Lyne, et al.
Publicado: (2014)

Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial Fibrillation
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2022)

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation
por: Lenglet, Aurélie, et al.
Publicado: (2022)

COVID‐19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data
por: Hernandez, Inmaculada, et al.
Publicado: (2021)

Pharmacotherapeutic management of chronic noncancer pain in primary care: lessons for pharmacists
por: Jouini, Ghaya, et al.
Publicado: (2014)

Prevalence and Management of Drug-Related Problems in Chronic Kidney Disease Patients by Severity Level: A Subanalysis of a Cluster Randomized Controlled Trial in Community Pharmacies
por: Quintana-Bárcena, Patricia, et al.
Publicado: (2018)

The process of learning the autogenic training relaxation technique and its benefits on the wellness of people living with HIV
por: Ramirez Garcia, Maria Pilar, et al.
Publicado: (2022)

Priority interventions to improve the management of chronic non-cancer pain in primary care: a participatory research of the ACCORD program
por: Lalonde, Lyne, et al.
Publicado: (2015)

“We’re Home Now”: How a Rehousing Intervention Shapes the Mental Well-Being of Inuit Adults in Nunavut, Canada
por: Perreault, Karine, et al.
Publicado: (2022)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adults
por: Boivin-Proulx, Laurie-Anne, et al.
Publicado: (2023)

Knowledge, attitudes and beliefs about chronic noncancer pain in primary care: A Canadian survey of physicians and pharmacists
por: Lalonde, Lyne, et al.
Publicado: (2014)

Pharmacy benefit considerations for continuous glucose monitoring acquisition: Vermont Medicaid experience
por: Hurteau, Lisa Brouillette, et al.
Publicado: (2023)

Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study
por: Dossa, Anara Richi, et al.
Publicado: (2015)

Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service
por: Hawkins, Kelsey L., et al.
Publicado: (2018)

Therapeutic Interchange of Parenteral Anticoagulants: Challenges for Pharmacy and Therapeutics Committees
por: Amin, Alpesh
Publicado: (2011)

Benefits of Utilizing Pharmacy Learners in an Inpatient Anticoagulation Education Service
por: Baker, Carrie, et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

An Analysis of Perceived and Actual Anticoagulant Knowledge among Independent Pharmacy Patients
por: Ware, Kenric B., et al.
Publicado: (2020)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
por: Ment, Jerome
Publicado: (2015)

Smc5/6 Is a Telomere-Associated Complex that Regulates Sir4 Binding and TPE
por: Moradi-Fard, Sarah, et al.
Publicado: (2016)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

MRI Screening for Chronic Anticoagulation in Atrial Fibrillation
por: Fisher, Mark
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Anticoagulant Therapy for Frail Patients with Atrial Fibrillation
por: Hori, Hiroshi, et al.
Publicado: (2021)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
por: Ko, Darae, et al.
Publicado: (2021)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bne0mi6r0icegarr0aui2f27p1